Alzahrani, A S <br/><br/>
123I isotope as a diagnostic agent in the follow-up of patients with differentiated thyroid cancer: comparison with post 131I therapy whole body scanning.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Nov 2001 
 - 5294-300 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0021-972X 
<br/><br/><label>Standard No.: </label>10.1210/jcem.86.11.8030  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Female<br/>Humans<br/>Iodine Radioisotopes--therapeutic use<br/>Male<br/>Middle Aged<br/>Radionuclide Imaging<br/>Radiopharmaceuticals--therapeutic use<br/>Thyroglobulin--metabolism<br/>Thyroid Neoplasms--diagnostic imaging<br/>Whole-Body Counting